Gena Wang, an analyst from Barclays, maintained the Hold rating on Vertex Pharmaceuticals (VRTX – Research Report). The associated price ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today provided updates on multiple kidney diseases in its pipeline including IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

CHANGZHOU, China, Oct. 24, 2024 /PRNewswire/ -- Trinasolar has recently reached a significant milestone, delivering more than ...

Learn more about it. Whether you’re ready or not, the holidays will be here in a flash, and retailers are starting to market their 2024 Advent calendars. These calendars help you count down the ...

VVDN Technologies, a global provider of Software, Product Engineering, Electronics Manufacturing Services, and Solutions, ...